Author: John A. Wagner, MD, PhD on June 25, 2021 
Every year, the Clinical and Translational Science (CTS) Editorial Team has the opportunity and privilege to present a CTS award at the annual meeting of ASCPT, our sponsoring society. This year, we recognized the CTS paper that most represents the type of research CTS strives to publish: timely, impactful, influential, carefully researched, and exemplary of translational science. The choice this year was a very difficult one, as we had many outstanding papers to choose from over the one-year interval under consideration; however, after careful review and deliberation, it was clear to our team that the paper, “Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs,” by Blinova et al., was the perfect choice. Not only is this paper already impactful with 13 citations to date, but it is also the best fit as an exemplar of an outstanding, highly translational CTS paper. Please have a read if you haven’t already; this is a terrific bench-to-bedside paper, which demonstrates that the immaturity and inherent variability of iPSC‐cardiomyocytes can significantly obscure subject‐specific drug response prediction in the clinic–a very important finding.
We did not have the opportunity to celebrate in person at the ASCPT annual meeting this year, but we wanted to again wish hearty congratulations to Dr. Ksenia Blinova, first and corresponding author of the paper, for a job well done. On behalf of the entire CTS Editorial Team, it is my honor to congratulate Dr. Blinova on winning the 2021 CTS Award. The Editorial Team strives to accept high quality original research in the field of translational science, and selection of Dr. Blinova’s article also celebrates core bench-to-bedside translational research. Dr. Blinova, who has a PhD in physics and mathematics from Moscow State University, is Assistant Division Director at the FDA’s Center for Devices and Radiological Health, Office of Science and Engineering Laboratories. She asked us to also acknowledge the leadership of Dr. David Strauss (FDA) and her co-authors, including her equally contributing first co-author, Derek Schocken, now at Duke University.
Stay tuned for the 2022 CTS award winner, which will be announced during the 2022 ASCPT meeting, and consider CTS for your next exemplary translational science submission.
The comment feature is locked by administrator.